Aaby Peter, Jensen Henrik, Gomes Joaquim, Fernandes Manual, Lisse Ida Maria
Bandim Health Project, Apartado 861, Bissau, Guinea-Bissau.
Int J Epidemiol. 2004 Apr;33(2):374-80. doi: 10.1093/ije/dyh005.
and objective Previous studies from areas with high mortality in West Africa have not found diphtheria-tetanus-pertussis (DTP) vaccine to be associated with the expected reduction in mortality, a few studies suggesting increased mortality. We therefore examined mortality when DTP was first introduced in rural areas of Guinea-Bissau in 1984-1987. Setting Twenty villages in four regions have been followed with bi-annual examinations since 1979.
In all, 1657 children aged 2-8 months. Design Children were weighed when attending the bi-annual examinations and they were vaccinated whenever vaccines were available. DTP was introduced in the beginning of 1984, oral polio vaccine later that year. We examined mortality for children aged 2-8 months who had received DTP and compared them with children who had not been vaccinated because they were absent, vaccines were not available, or they were sick.
Mortality over the next 6 months from the day of examination for vaccinated and unvaccinated children.
Prior to the introduction of vaccines, children who were absent at a village examination had the same mortality as children who were present. During 1984-1987, children receiving DTP at 2-8 months of age had higher mortality over the next 6 months, the mortality rate ratio (MR) being 1.92 (95% CI: 1.04, 3.52) compared with DTP-unvaccinated children, adjusting for age, sex, season, period, BCG, and region. The MR was 1.81 (95% CI: 0.95, 3.45) for the first dose of DTP and 4.36 (95% CI: 1.28, 14.9) for the second and third dose. BCG was associated with slightly lower mortality (MR = 0.63, 95% CI: 0.30, 1.33), the MR for DTP and BCG being significantly inversed. Following subsequent visits and further vaccinations with DTP and measles vaccine, there was no difference in vaccination coverage and subsequent mortality between the DTP-vaccinated group and the initially DTP-unvaccinated group (MR = 1.06, 95% CI: 0.78, 1.44).
In low-income countries with high mortality, DTP as the last vaccine received may be associated with slightly increased mortality. Since the pattern was inversed for BCG, the effect is unlikely to be due to higher-risk children having received vaccination. The role of DTP in high mortality areas needs to be clarified.
以往来自西非高死亡率地区的研究未发现白喉-破伤风-百日咳(DTP)疫苗与预期的死亡率降低相关,少数研究表明死亡率有所增加。因此,我们研究了1984 - 1987年在几内亚比绍农村地区首次引入DTP疫苗时的死亡率情况。研究地点:自1979年起,对四个地区的20个村庄进行每两年一次的检查跟踪。
共有1657名年龄在2至8个月的儿童。研究设计:儿童在每两年一次的检查时称重,有疫苗时即进行接种。DTP疫苗于1984年初引入,同年晚些时候引入口服脊髓灰质炎疫苗。我们检查了接种DTP疫苗的2至8个月龄儿童的死亡率,并将其与因缺席、无疫苗可用或患病而未接种疫苗的儿童进行比较。
接种和未接种疫苗儿童从检查日起接下来6个月的死亡率。
在引入疫苗之前,在村庄检查时缺席的儿童与在场儿童的死亡率相同。在1984 - 1987年期间,2至8个月龄接种DTP疫苗的儿童在接下来6个月的死亡率更高,与未接种DTP疫苗的儿童相比,调整年龄、性别、季节、时间段、卡介苗(BCG)和地区后,死亡率比值(MR)为1.92(95%可信区间:1.04, 3.52)。第一剂DTP的MR为1.81(95%可信区间:0.95, 3.45),第二剂和第三剂的MR为4.36(95%可信区间:1.28, 14.9)。BCG与略低的死亡率相关(MR = 0.63, 95%可信区间:0.30, 1.33),DTP和BCG的MR显著相反。在随后的随访以及进一步接种DTP和麻疹疫苗后,接种DTP疫苗组与最初未接种DTP疫苗组之间的疫苗接种覆盖率和随后的死亡率没有差异(MR = 1.06, 95%可信区间:0.78, 1.44)。
在高死亡率的低收入国家,作为最后接种的疫苗,DTP可能与死亡率略有增加相关。由于BCG呈现相反的模式,这种影响不太可能是由于高风险儿童接种了疫苗所致。DTP在高死亡率地区的作用需要进一步明确。